"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

Multiple sclerosis (MS) is a disabling ... with arrhythmias requiring treatment with Class 1a or III anti-arrhythmic drugs with ischemic heart disease, heart failure, history of cardiac arrest or ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...

The seven-year MS-STAT study, which involved almost 1,000 patients over 31 sites across the UK, concluded that simvastatin is ...

SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and ...

Abnormal eye movements, asymmetric pupillary responses, sudden reading problems or the appearance of diplopia are all yellow ...

Labour is yet to drop proposals for the DWP to replace the personal independence payment (PIP) with one-off grants and ...

Significance of acquisition: Allows use of mRNA genetic biomarkers to study inflammatory changes in the brain in such diseases as autism, post-traumatic stress disorder (PTSD), Parkinson's disease, ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...